Japan-Specific Approval For Hemlibra In Acquired Hemophilia A
New Data Also In Mild/Moderate Disease
Hemlibra receives new approval in Japan intractable disease indication, while positive Phase III results in mild/moderate disease hemophilia A will support a planned EU filing in this setting.
